Cargando…

Antenatal corticosteroids and fetal lung immaturity in preterm birth

BACKGROUND: Respiratory distress syndrome (RDS), a consequence of lung immaturity, is a serious complication of preterm birth and the primary cause of early neonatal mortality. Administration of antenatal steroids is a standard care method for mothers with anticipated preterm labor. However, the ges...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Iyad, Batta, Rita Imad, Yaseen, Reem Mahmoud, Hasson, Jawad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305388/
https://www.ncbi.nlm.nih.gov/pubmed/32577553
http://dx.doi.org/10.1016/j.heliyon.2020.e04116
_version_ 1783548450056437760
author Ali, Iyad
Batta, Rita Imad
Yaseen, Reem Mahmoud
Hasson, Jawad
author_facet Ali, Iyad
Batta, Rita Imad
Yaseen, Reem Mahmoud
Hasson, Jawad
author_sort Ali, Iyad
collection PubMed
description BACKGROUND: Respiratory distress syndrome (RDS), a consequence of lung immaturity, is a serious complication of preterm birth and the primary cause of early neonatal mortality. Administration of antenatal steroids is a standard care method for mothers with anticipated preterm labor. However, the gestational age range at which antenatal corticosteroids (ACS) provide benefit has been subjected to debate. This study aimed to find the prevalence of ACS use in patients that developed/did not develop RDS. METHODS: This cross-sectional study was conducted at Rafidia governmental surgical hospital. It is based on the data obtained from the files of mothers who gave birth to premature babies and from a face-to-face interview. One hundred and twenty-eight data collection forms were completed over a period of seven months. RESULTS: Approximately 64% of mothers, mothers who gave birth to premature babies, were given ACS, and about 33% of premature neonates developed RDS. Mothers who gave birth to newborns with RDS have lower odds of being administered ACS by 44% (OR = 0.44, CI = 0.202–0.94, p value = 0.034). However, the association became statistically not significant after adjusting gestational age, birth weight, gender, mother's age, intrauterine growth restriction (IUGR), mode of delivery and gestational hypertension (OR = 0.462, CI = 0.137–1.56, p value = 0.212). Higher risk of RDS was significantly associated with lower gestational age (p-value < 0.001) and IUGR after adjustment (p value = 0.035). However, no significant association could be found between RDS and mode of delivery (p value = 0.730), maternal age (p value = 0.63) and gender of the baby (p value = 0.22). CONCLUSIONS: the overall prevalence of RDS in preterm infants was 33.3% and the identified risk factors were lower gestational age and IUGR. We showed that the administration of ACS wasn't significantly associated with the development of RDS after adjusting gestational age, birth weight, gender, mother's age, IUGR, mode of delivery and gestational hypertension, as the administration of ACS didn't fully meet the international guidelines.
format Online
Article
Text
id pubmed-7305388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73053882020-06-22 Antenatal corticosteroids and fetal lung immaturity in preterm birth Ali, Iyad Batta, Rita Imad Yaseen, Reem Mahmoud Hasson, Jawad Heliyon Article BACKGROUND: Respiratory distress syndrome (RDS), a consequence of lung immaturity, is a serious complication of preterm birth and the primary cause of early neonatal mortality. Administration of antenatal steroids is a standard care method for mothers with anticipated preterm labor. However, the gestational age range at which antenatal corticosteroids (ACS) provide benefit has been subjected to debate. This study aimed to find the prevalence of ACS use in patients that developed/did not develop RDS. METHODS: This cross-sectional study was conducted at Rafidia governmental surgical hospital. It is based on the data obtained from the files of mothers who gave birth to premature babies and from a face-to-face interview. One hundred and twenty-eight data collection forms were completed over a period of seven months. RESULTS: Approximately 64% of mothers, mothers who gave birth to premature babies, were given ACS, and about 33% of premature neonates developed RDS. Mothers who gave birth to newborns with RDS have lower odds of being administered ACS by 44% (OR = 0.44, CI = 0.202–0.94, p value = 0.034). However, the association became statistically not significant after adjusting gestational age, birth weight, gender, mother's age, intrauterine growth restriction (IUGR), mode of delivery and gestational hypertension (OR = 0.462, CI = 0.137–1.56, p value = 0.212). Higher risk of RDS was significantly associated with lower gestational age (p-value < 0.001) and IUGR after adjustment (p value = 0.035). However, no significant association could be found between RDS and mode of delivery (p value = 0.730), maternal age (p value = 0.63) and gender of the baby (p value = 0.22). CONCLUSIONS: the overall prevalence of RDS in preterm infants was 33.3% and the identified risk factors were lower gestational age and IUGR. We showed that the administration of ACS wasn't significantly associated with the development of RDS after adjusting gestational age, birth weight, gender, mother's age, IUGR, mode of delivery and gestational hypertension, as the administration of ACS didn't fully meet the international guidelines. Elsevier 2020-06-18 /pmc/articles/PMC7305388/ /pubmed/32577553 http://dx.doi.org/10.1016/j.heliyon.2020.e04116 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ali, Iyad
Batta, Rita Imad
Yaseen, Reem Mahmoud
Hasson, Jawad
Antenatal corticosteroids and fetal lung immaturity in preterm birth
title Antenatal corticosteroids and fetal lung immaturity in preterm birth
title_full Antenatal corticosteroids and fetal lung immaturity in preterm birth
title_fullStr Antenatal corticosteroids and fetal lung immaturity in preterm birth
title_full_unstemmed Antenatal corticosteroids and fetal lung immaturity in preterm birth
title_short Antenatal corticosteroids and fetal lung immaturity in preterm birth
title_sort antenatal corticosteroids and fetal lung immaturity in preterm birth
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305388/
https://www.ncbi.nlm.nih.gov/pubmed/32577553
http://dx.doi.org/10.1016/j.heliyon.2020.e04116
work_keys_str_mv AT aliiyad antenatalcorticosteroidsandfetallungimmaturityinpretermbirth
AT battaritaimad antenatalcorticosteroidsandfetallungimmaturityinpretermbirth
AT yaseenreemmahmoud antenatalcorticosteroidsandfetallungimmaturityinpretermbirth
AT hassonjawad antenatalcorticosteroidsandfetallungimmaturityinpretermbirth